Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Long-Term Follow-Up Demonstrates Ongoing Efficacy Benefit of 131I-Apamistamab-led Allogeneic Hematopoietic Cell Transplantation in Older Patients with Active, R/R AML in the Phase 3 SIERRA Trial

Stuart Seropian,Boglarka Gyurkocza,Rajneesh Nath,Hannah Choe,Mark Litzow,Camille Abboud,Nebu Koshy,Patrick Stiff,Benjamin Tomlinson,Sunil Abhyankar,James Foran,Sameem Abedin,George Chen,Zaid Al-Kadhimi,Partow Kebriaei,Mitchell Sabloff,Johnnie Orozco,Katarzyna Jamieson,Margarida Silverman,Koen Van Besien,Michael Schuster,Arjun Law,Sebastian Mayer,Hillard Lazarus,Jennifer Spross, Kate Li,Madhuri Vusirikala,Brenda Sandmaier,John Pagel,Avinash Desai,Sergio Giralt

Clinical Lymphoma Myeloma and Leukemia（2024）

Cited 0|Views8
Key words
AML,relapsed/refractory,131I-apamistamab,allogeneic stem cell transplant,radioimmunoconjugate,phase 3
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined